The current valuation score of Sunshine Biopharma Inc is 9.76, ranking 3 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -0.93, which is -132.87% below the recent high of 0.31 and -127.35% above the recent low of -2.12.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.